Untitled Document

Activity Overview

prIME Oncology invites you to view the Webcast of selected presentations and downloadable slides from the Multidisciplinary Expert PracticeSM in Breast Cancer meeting, held November 2010 in Brussels, Belgium.

Faculty

Co-Chairs

Christos Markopoulos, MD, PhD
Athens University Medical School
Athens, Greece

Cornelis van de Velde, MD, PhD
Leiden University
Leiden, the Netherlands

Faculty

Ahmad Awada, MD, PhD
Institute Jules Bordet
Brussels, Belgium

Robert Coleman, MD
Weston Park Hospital
Sheffield, United Kingdom

Ian Kunkler, MD
University of Edinburgh
Edinburgh, Scotland

Ariel Saracco, MD
Bröstcentrum SöS
Södersjukhuset
Stockholm, Sweden

Giuseppe Viale, MD, PhD
European Institute of Oncology
Milan, Italy

 

Expert Discussion

 

Clinical Case

 

Downloadable Slides



Video and downloadable slides

Topics

Hot topics in breast oncology in 2010: Practice changing Information
  • Surgical oncology
    Christos Markopoulos, MD, PhD
  • Pathology
    Giuseppe Viale, MD, PhD
  • Radiation oncology
    Ian Kunkler, MD
  • Medical oncology
    Robert Coleman, MD

Case #1 – Endocrine-responsive postmenopausal breast cancer - a clinicopathology discussion
All Faculty

Case #5 – Metastatic triple-negative breast cancer
Ahmad Awada, MD, PhD

Target Audience

This educational activity is designed for Pan-European medical oncologists, radiation oncologists, surgical oncologists, pathologists and other healthcare providers involved active in the management of patients with breast cancer.

The information in this activity is intended for healthcare professionals based outside of the United States. You will be asked to provide your credentials before accessing the Webcast and slides. This activity may contain information on products outside the approved indications where you practice.














Support

Support for this activity is provided by Eisai Europe Limited; Genomic Health, Inc.; GlaxoSmithKline; Novartis Oncology; and sanofi-aventis.

amgen

eisai

roche

genomic health

gsk